MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹0.50 Cr | ₹0.65 Cr | ₹6.04 Cr | ₹7.84 Cr | ₹3.58 Cr |
What is the latest Total Non-Current Liabilities ratio of MEDICAMEN BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹0.50 Cr |
Mar2023 | ₹0.65 Cr |
Mar2022 | ₹6.04 Cr |
Mar2021 | ₹7.84 Cr |
Mar2020 | ₹3.58 Cr |
How is Total Non-Current Liabilities of MEDICAMEN BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.50 Cr | -23.54 | |
Mar2023 | ₹0.65 Cr | -89.23 | |
Mar2022 | ₹6.04 Cr | -23.04 | |
Mar2021 | ₹7.84 Cr | 118.92 | |
Mar2020 | ₹3.58 Cr | - |
Compare Total Non-Current Liabilities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹481.8 Cr | -2.9% | -12.7% | -10.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -2.9% |
-12.7% |
-10.6% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses